Moderated by pharmaphorum’s web editor Nicole Raleigh, the session featured three expert panellists: Mo Rice, Vice President ...
Fintel reports that on November 18, 2025, B of A Securities maintained coverage of Jazz Pharmaceuticals (NasdaqGS:JAZZ) with ...
Achieving proper drug dosages , particularly for pediatric patients, has been a pivotal point of research in pharmacology.
You've disabled cookies in your web browser. A third-party browser plugin, such as Ghostery or NoScript, is preventing ...
Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
Arrowhead Pharmaceuticals faces key FDA decisions, legal challenges, and trial results. Read the latest analysis on the stock ...
Joint promotion of the Parsortix platform and QIAGEN’s molecular technologiesOpportunity for the development of a companion diagnostic assayGuildford, UK, – 18 November 2025 – CELLBXHEALTH plc (AIM: ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...
On November 13, 2025, effective November 14, 2025 the Securities and Exchange Commission (“Commission”), in Administrative Proceeding File No. 3-22541, in Release No. 104178 issued an Order Making ...
PRNewswire/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay Pharmaceutical Group (DPG), is dedicated to providing patients with rare diseases access to orphan drugs. Medunik ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback